| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF10 ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 LHX8 ZNF333 ZNF700 ZNF876P ZNF417 PRDM16 TAF1L ZNF681 ZNF669 ZNF551 ZNF77 | 1.28e-10 | 1459 | 84 | 26 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF10 IKZF3 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 LHX8 ZNF333 ZNF700 ZNF876P ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 2.08e-09 | 1412 | 84 | 24 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 IKZF1 ZBTB41 ZNF333 ZNF876P ZNF417 PRDM16 ZNF681 ZNF551 | 3.29e-06 | 1244 | 84 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 IKZF1 ZBTB41 ZNF333 ZNF876P ZNF417 PRDM16 ZNF681 ZNF551 | 4.45e-06 | 1271 | 84 | 18 | GO:0000987 |
| Domain | Znf_C2H2-like | ZNF10 ZNF410 ZC3H7A IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 ZFTA IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 3.77e-16 | 796 | 83 | 26 | IPR015880 |
| Domain | ZnF_C2H2 | ZNF10 ZNF410 ZC3H7A IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 ZFTA IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 5.40e-16 | 808 | 83 | 26 | SM00355 |
| Domain | - | ZNF10 ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 1.16e-15 | 679 | 83 | 24 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF10 ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 1.89e-15 | 694 | 83 | 24 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF10 ZNF410 ZC3H7A IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 2.13e-15 | 775 | 83 | 25 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF10 ZNF410 ZC3H7A IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 2.26e-15 | 777 | 83 | 25 | PS00028 |
| Domain | Znf_C2H2 | ZNF10 ZNF410 ZC3H7A IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 5.09e-15 | 805 | 83 | 25 | IPR007087 |
| Domain | zf-C2H2 | ZNF10 ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 MTF1 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 1.97e-14 | 693 | 83 | 23 | PF00096 |
| Domain | zf-C2H2_6 | ZNF10 ZNF154 ZNF670 ZNF658 ZNF587 ZNF540 ZNF558 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 3.33e-14 | 314 | 83 | 17 | PF13912 |
| Domain | KRAB | ZNF10 ZNF154 ZNF670 ZNF658 ZNF587 ZNF540 ZNF558 ZNF333 ZNF700 ZNF417 ZNF681 ZNF669 ZNF551 ZNF77 | 5.61e-10 | 358 | 83 | 14 | PS50805 |
| Domain | KRAB | ZNF10 ZNF154 ZNF670 ZNF658 ZNF587 ZNF540 ZNF558 ZNF333 ZNF700 ZNF417 ZNF681 ZNF669 ZNF551 ZNF77 | 5.61e-10 | 358 | 83 | 14 | PF01352 |
| Domain | KRAB | ZNF10 ZNF154 ZNF670 ZNF658 ZNF587 ZNF540 ZNF558 ZNF333 ZNF700 ZNF417 ZNF681 ZNF669 ZNF551 ZNF77 | 8.32e-10 | 369 | 83 | 14 | SM00349 |
| Domain | KRAB | ZNF10 ZNF154 ZNF670 ZNF658 ZNF587 ZNF540 ZNF558 ZNF333 ZNF700 ZNF417 ZNF681 ZNF669 ZNF551 ZNF77 | 8.61e-10 | 370 | 83 | 14 | IPR001909 |
| Domain | CTCK_1 | 2.85e-03 | 18 | 83 | 2 | PS01185 | |
| Domain | Cyclophilin-type_PPIase_CS | 3.18e-03 | 19 | 83 | 2 | IPR020892 | |
| Domain | ADH_SF_Zn-type | 3.18e-03 | 19 | 83 | 2 | IPR002085 | |
| Domain | Cyclophilin-type_PPIase | 3.88e-03 | 21 | 83 | 2 | IPR024936 | |
| Domain | Cyclophilin-like_dom | 4.25e-03 | 22 | 83 | 2 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 4.25e-03 | 22 | 83 | 2 | PS50072 | |
| Domain | Pro_isomerase | 4.25e-03 | 22 | 83 | 2 | PF00160 | |
| Domain | - | 4.25e-03 | 22 | 83 | 2 | 2.40.100.10 | |
| Domain | CT | 4.25e-03 | 22 | 83 | 2 | SM00041 | |
| Domain | Cyclophilin-type_PPIase_dom | 4.25e-03 | 22 | 83 | 2 | IPR002130 | |
| Domain | CSA_PPIASE_1 | 4.25e-03 | 22 | 83 | 2 | PS00170 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 11937265 | ||
| Pubmed | Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. | 1.36e-08 | 3 | 84 | 3 | 9560339 | |
| Pubmed | Analysis of Ikaros family splicing variants in human hematopoietic lineages. | 1.36e-08 | 3 | 84 | 3 | 20432734 | |
| Pubmed | 1.36e-08 | 3 | 84 | 3 | 27502439 | ||
| Pubmed | Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma. | 1.36e-08 | 3 | 84 | 3 | 18332232 | |
| Pubmed | Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. | 1.35e-07 | 5 | 84 | 3 | 10978333 | |
| Pubmed | 2.97e-07 | 181 | 84 | 7 | 37372979 | ||
| Pubmed | ZNF410 IKZF2 ZNF670 ZFP36L2 MTF1 ZIC5 ZBTB41 PLCG1 LHX8 PRDM16 ZNF681 | 3.95e-06 | 808 | 84 | 11 | 20412781 | |
| Pubmed | A molecular dissection of the repression circuitry of Ikaros. | 4.85e-06 | 14 | 84 | 3 | 12015313 | |
| Pubmed | Helios deficiency has minimal impact on T cell development and function. | 5.76e-06 | 2 | 84 | 2 | 19620299 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31558666 | ||
| Pubmed | A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS. | 5.76e-06 | 2 | 84 | 2 | 34155405 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 24509510 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33499314 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 11173542 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9155026 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 31151137 | ||
| Pubmed | Impaired tissue homing by the Ikzf3N159S variant is mediated by interfering with Ikaros function. | 5.76e-06 | 2 | 84 | 2 | 37662955 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 33182226 | ||
| Pubmed | Critical function of Ikaros in controlling Aiolos gene expression. | 5.76e-06 | 2 | 84 | 2 | 17383641 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 27881177 | ||
| Pubmed | Predominant interaction of both Ikaros and Helios with the NuRD complex in immature thymocytes. | 5.76e-06 | 2 | 84 | 2 | 17681952 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 22931634 | ||
| Pubmed | Ikaros promotes early-born neuronal fates in the cerebral cortex. | 1.28e-05 | 19 | 84 | 3 | 23382203 | |
| Pubmed | Increased renal oxidative stress in salt-sensitive human GRK4γ486V transgenic mice. | 1.73e-05 | 3 | 84 | 2 | 28189851 | |
| Pubmed | The genomic landscape of hypodiploid acute lymphoblastic leukemia. | 1.73e-05 | 3 | 84 | 2 | 23334668 | |
| Pubmed | MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses. | 1.73e-05 | 3 | 84 | 2 | 30842214 | |
| Pubmed | The CD8alpha gene locus is regulated by the Ikaros family of proteins. | 1.73e-05 | 3 | 84 | 2 | 12504015 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 37651195 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 25446972 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 24328678 | ||
| Pubmed | The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. | 3.45e-05 | 4 | 84 | 2 | 24292623 | |
| Pubmed | Expression of adiponectin and its receptors in type 1 diabetes mellitus in human and mouse retinas. | 3.45e-05 | 4 | 84 | 2 | 23922494 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 32655569 | ||
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 10766745 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 12719437 | ||
| Pubmed | 8.59e-05 | 6 | 84 | 2 | 27941021 | ||
| Pubmed | Ikaros and Aiolos inhibit pre-B-cell proliferation by directly suppressing c-Myc expression. | 8.59e-05 | 6 | 84 | 2 | 20566697 | |
| Pubmed | 1.20e-04 | 7 | 84 | 2 | 18682727 | ||
| Pubmed | Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells. | 1.20e-04 | 7 | 84 | 2 | 26823144 | |
| Pubmed | Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. | 1.20e-04 | 7 | 84 | 2 | 10357820 | |
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 22142223 | ||
| Pubmed | 2.05e-04 | 9 | 84 | 2 | 19734904 | ||
| Pubmed | Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. | 2.05e-04 | 9 | 84 | 2 | 22638570 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CEP170 ZFP36L2 DOCK11 RPS6KA2 MACF1 USP54 DPP8 PPIP5K2 SEC23B | 2.35e-04 | 861 | 84 | 9 | 36931259 |
| Pubmed | 2.56e-04 | 10 | 84 | 2 | 33773096 | ||
| Pubmed | 2.60e-04 | 51 | 84 | 3 | 20682687 | ||
| Pubmed | Impact of genomic polymorphism on arterial hypertension after aortic coarctation repair. | 3.13e-04 | 11 | 84 | 2 | 20537417 | |
| Pubmed | Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. | 3.13e-04 | 11 | 84 | 2 | 10204490 | |
| Pubmed | 3.13e-04 | 11 | 84 | 2 | 20577119 | ||
| Pubmed | 3.75e-04 | 12 | 84 | 2 | 22981605 | ||
| Pubmed | Ikaros confers early temporal competence to mouse retinal progenitor cells. | 4.42e-04 | 13 | 84 | 2 | 18940586 | |
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 24478091 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 23821580 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 20676357 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 19605412 | ||
| Pubmed | 5.93e-04 | 15 | 84 | 2 | 14580349 | ||
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 19627984 | ||
| Pubmed | RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation. | 6.77e-04 | 16 | 84 | 2 | 30760870 | |
| Pubmed | 6.77e-04 | 16 | 84 | 2 | 17715346 | ||
| Pubmed | 7.66e-04 | 17 | 84 | 2 | 15767674 | ||
| Pubmed | Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR. | 7.66e-04 | 17 | 84 | 2 | 25331958 | |
| Pubmed | 8.41e-04 | 76 | 84 | 3 | 22323595 | ||
| Pubmed | 8.60e-04 | 18 | 84 | 2 | 16854408 | ||
| Pubmed | Mesenchymal-epithelial interaction regulates gastrointestinal tract development in mouse embryos. | 8.60e-04 | 18 | 84 | 2 | 35830795 | |
| Pubmed | 9.41e-04 | 79 | 84 | 3 | 18978678 | ||
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 12447396 | ||
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 36189989 | ||
| Pubmed | 1.06e-03 | 20 | 84 | 2 | 24082127 | ||
| Pubmed | 1.09e-03 | 186 | 84 | 4 | 20673868 | ||
| Pubmed | 1.09e-03 | 186 | 84 | 4 | 20452482 | ||
| Pubmed | Long-range enhancers regulating Myc expression are required for normal facial morphogenesis. | 1.17e-03 | 21 | 84 | 2 | 24859337 | |
| Pubmed | 1.29e-03 | 22 | 84 | 2 | 18628988 | ||
| Pubmed | 1.29e-03 | 22 | 84 | 2 | 9811459 | ||
| Pubmed | 1.31e-03 | 497 | 84 | 6 | 23414517 | ||
| Pubmed | PARP11 ZC3H7A ZFP36L2 MTF1 ODR4 PPIL2 NIT1 NKTR PLCG1 FBXO21 | 1.35e-03 | 1327 | 84 | 10 | 32694731 | |
| Pubmed | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | 1.46e-03 | 342 | 84 | 5 | 23128233 | |
| Pubmed | 1.54e-03 | 24 | 84 | 2 | 28324027 | ||
| Pubmed | 1.67e-03 | 25 | 84 | 2 | 17355643 | ||
| Pubmed | 1.67e-03 | 25 | 84 | 2 | 29475039 | ||
| Pubmed | 1.67e-03 | 25 | 84 | 2 | 15809042 | ||
| Pubmed | 1.68e-03 | 916 | 84 | 8 | 32203420 | ||
| Pubmed | 1.86e-03 | 215 | 84 | 4 | 36808153 | ||
| Pubmed | 1.95e-03 | 27 | 84 | 2 | 18685082 | ||
| Pubmed | Generation and analysis of 280,000 human expressed sequence tags. | 2.01e-03 | 368 | 84 | 5 | 8889549 | |
| Pubmed | 2.02e-03 | 103 | 84 | 3 | 10574462 | ||
| Pubmed | 2.02e-03 | 103 | 84 | 3 | 21706016 | ||
| Pubmed | Sohlh2 affects differentiation of KIT positive oocytes and spermatogonia. | 2.09e-03 | 28 | 84 | 2 | 19014927 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 2.11e-03 | 372 | 84 | 5 | 22939624 | |
| Pubmed | 2.23e-03 | 226 | 84 | 4 | 31452512 | ||
| Pubmed | 2.24e-03 | 29 | 84 | 2 | 38972757 | ||
| Pubmed | Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. | 2.40e-03 | 30 | 84 | 2 | 24292625 | |
| Interaction | MID2 interactions | ZNF410 IKZF3 FAM161A ZNF587 USP54 ZNF417 ZBTB42 PRDM16 ZNF669 | 1.12e-06 | 267 | 80 | 9 | int:MID2 |
| Interaction | TSGA10 interactions | 4.21e-05 | 97 | 80 | 5 | int:TSGA10 | |
| Interaction | BICD2 interactions | ZC3H7A ZNF670 FAM161A USP54 PPIP5K2 ZNF417 CNN2 ASAP1 ZNF669 | 4.77e-05 | 426 | 80 | 9 | int:BICD2 |
| Interaction | CCDC136 interactions | 5.72e-05 | 169 | 80 | 6 | int:CCDC136 | |
| Interaction | CCDC13 interactions | 5.81e-05 | 53 | 80 | 4 | int:CCDC13 | |
| Cytoband | 19q13.43 | 5.61e-04 | 87 | 84 | 3 | 19q13.43 | |
| Cytoband | 5q35 | 8.16e-04 | 23 | 84 | 2 | 5q35 | |
| Cytoband | 1q44 | 1.11e-03 | 110 | 84 | 3 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.47e-03 | 797 | 84 | 6 | chr19p13 | |
| Cytoband | 12q24.33 | 3.53e-03 | 48 | 84 | 2 | 12q24.33 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF10 ZNF410 IKZF3 IKZF2 ZNF154 ZNF670 ZNF658 ZIC5 ZNF587 ZNF540 ZNF558 IKZF1 ZBTB41 ZNF619 ZNF333 ZNF700 ZNF417 ZBTB42 PRDM16 ZNF681 ZNF669 ZNF551 ZNF77 | 8.85e-17 | 718 | 63 | 23 | 28 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.43e-06 | 186 | 84 | 6 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.18e-06 | 200 | 84 | 6 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 9.93e-06 | 151 | 84 | 5 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 1.16e-05 | 156 | 84 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.66e-05 | 168 | 84 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 1.97e-05 | 174 | 84 | 5 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-05 | 179 | 84 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.78e-05 | 187 | 84 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-05 | 190 | 84 | 5 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-05 | 191 | 84 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.16e-05 | 192 | 84 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.23e-05 | 193 | 84 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.40e-05 | 195 | 84 | 5 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.48e-05 | 196 | 84 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.57e-05 | 197 | 84 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.57e-05 | 197 | 84 | 5 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.57e-05 | 197 | 84 | 5 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-GABAergic_neurons|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.57e-05 | 197 | 84 | 5 | 21f3ef7c3c10b4e3adde431097dfdcd513c74a95 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.57e-05 | 197 | 84 | 5 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.65e-05 | 198 | 84 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 199 | 84 | 5 | b270d8274249103d3a1b4a4f8601c92fde007ed7 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.74e-05 | 199 | 84 | 5 | 28cec7122b143373f1c7c94acf35bf8f896e0d57 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.74e-05 | 199 | 84 | 5 | 69793ef363618030e4546877b3095c587617909f | |
| ToppCell | Severe_COVID-19-T/NK|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.74e-05 | 199 | 84 | 5 | ace179b860513179e9275ed40ae1985a98385026 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.74e-05 | 199 | 84 | 5 | c8a2c94809b2134b51bb9868b63cb280b490f3fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.83e-05 | 200 | 84 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.83e-05 | 200 | 84 | 5 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 3.83e-05 | 200 | 84 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 139 | 84 | 4 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.47e-04 | 141 | 84 | 4 | 330f944b38c3170dfc79ab033fae7b9ab71e840d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-04 | 147 | 84 | 4 | 2d9044ddf01b6838a44a4518b442d7e7cb0bf910 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 149 | 84 | 4 | c9334f319a0c943268e54b6f0c9446736172c3a9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 2.06e-04 | 154 | 84 | 4 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 155 | 84 | 4 | cd2f3ad4f131588325a667b6724e530d821fbe30 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 155 | 84 | 4 | 9b26ade19488511c72b64335011d2dcd81e8f167 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 155 | 84 | 4 | 4246709e27703b94529369abbed5763e4002e79d | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Trm_Th1/Th17|blood / Manually curated celltypes from each tissue | 2.22e-04 | 157 | 84 | 4 | c99cb26d831c25038f2aa1b1c0f7ba52facb2e7a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 159 | 84 | 4 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 159 | 84 | 4 | f7803f7b4e0379ae8256ec53110833bedee7db98 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 159 | 84 | 4 | 6e2d38e78d2ef7803e8bb154b5c788bf62a41045 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.33e-04 | 159 | 84 | 4 | 7065062fce248e0458932a22dfcc25a5b5a70cbd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-04 | 159 | 84 | 4 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 161 | 84 | 4 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-04 | 163 | 84 | 4 | 8a4931c9fdaedcf6c319157821d3556cd25fc9e5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-04 | 164 | 84 | 4 | f4de9f18134a06f3d7fcf5b50b8e21c1506e2083 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 164 | 84 | 4 | e9e5a1462d8ed60b2e5bf603c8c47eb85bce83d5 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-04 | 164 | 84 | 4 | dc22b1fef49c1557a0b63c536eaba574dfcab715 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-04 | 165 | 84 | 4 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-04 | 165 | 84 | 4 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.80e-04 | 167 | 84 | 4 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 2.93e-04 | 169 | 84 | 4 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | da607c1d068038d5a3d1117f6aa6e4c6f3552e97 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 169 | 84 | 4 | a14b46231e079a0fd9f3ca13d5d48113be76fd0f | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 3.00e-04 | 170 | 84 | 4 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 170 | 84 | 4 | bcbe5c44ef708c5f01dc7dd9aec7b436e1a62d56 | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 171 | 84 | 4 | 872b3b33cd3893d63c45617db0269692430b0e8b | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-04 | 171 | 84 | 4 | 3d26ef58fe5231373d7df9ac79d225546918cf82 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.14e-04 | 172 | 84 | 4 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 172 | 84 | 4 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 172 | 84 | 4 | 7af0713c40ea48f1e92c859c4fc4d8f0137c4415 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 172 | 84 | 4 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.21e-04 | 173 | 84 | 4 | 8ca650542655c27516029e5bace97ff1b9dcc256 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 175 | 84 | 4 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 175 | 84 | 4 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 175 | 84 | 4 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.35e-04 | 175 | 84 | 4 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-04 | 176 | 84 | 4 | 8e4600efeea095a92178cfd26d7c58db7dfc0c80 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.42e-04 | 176 | 84 | 4 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 177 | 84 | 4 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-04 | 178 | 84 | 4 | 00a5d8f47373be4792bf53914db63a1aedc2d77a | |
| ToppCell | B_cells-Naive_B_cells_|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.57e-04 | 178 | 84 | 4 | 71ac2eca5cf13a91f86b80690748b0788392dcfc | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 3.65e-04 | 179 | 84 | 4 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.65e-04 | 179 | 84 | 4 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.65e-04 | 179 | 84 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-04 | 180 | 84 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 3.72e-04 | 180 | 84 | 4 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-04 | 180 | 84 | 4 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.80e-04 | 181 | 84 | 4 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Severe-Lymphoid-T-innate_T|Severe / Condition, Lineage, Cell class and cell subclass | 3.80e-04 | 181 | 84 | 4 | 50ab8562552339d97e4f19aa6ae49fd797da492e | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.96e-04 | 183 | 84 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.96e-04 | 183 | 84 | 4 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 3.96e-04 | 183 | 84 | 4 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-04 | 184 | 84 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-04 | 184 | 84 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.05e-04 | 184 | 84 | 4 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 4.13e-04 | 185 | 84 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.13e-04 | 185 | 84 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 4.13e-04 | 185 | 84 | 4 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 186 | 84 | 4 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-04 | 186 | 84 | 4 | 9d576dce2c5deefef1adda16c6da7055c8d57f8f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 186 | 84 | 4 | 629b19447a63412cf1468160a0fedb5dbe02fd72 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-04 | 186 | 84 | 4 | bd3bd022b575d9b0ef90d50a5cb874085a827b77 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-04 | 186 | 84 | 4 | 8df32cde77bb0b3e2f37a9664e7b72ec99697395 | |
| Drug | Sotalol hydrochloride [959-24-0]; Down 200; 13uM; HL60; HT_HG-U133A | 7.88e-06 | 195 | 84 | 7 | 2918_DN | |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; PC3; HT_HG-U133A | 7.88e-06 | 195 | 84 | 7 | 4251_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A | 8.14e-06 | 196 | 84 | 7 | 2922_DN | |
| Drug | Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A | 8.14e-06 | 196 | 84 | 7 | 6744_DN | |
| Disease | Congenital dyserythropoietic anemia | 7.59e-05 | 5 | 82 | 2 | C0002876 | |
| Disease | disorder of pharynx | 2.88e-04 | 46 | 82 | 3 | MONDO_0020592 | |
| Disease | diastolic blood pressure, alcohol drinking | 3.34e-04 | 118 | 82 | 4 | EFO_0004329, EFO_0006336 | |
| Disease | L2 Acute Lymphoblastic Leukemia | 3.69e-04 | 50 | 82 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 4.14e-04 | 52 | 82 | 3 | C0023452 | |
| Disease | phosphatidylcholine 40:7 measurement | 5.83e-04 | 13 | 82 | 2 | EFO_0021477 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 6.63e-04 | 61 | 82 | 3 | C1961102 | |
| Disease | glucose measurement | 6.74e-04 | 380 | 82 | 6 | EFO_0004468 | |
| Disease | APOE carrier status, dementia | 6.95e-04 | 62 | 82 | 3 | EFO_0007659, MONDO_0001627 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 7.82e-04 | 15 | 82 | 2 | C2930967 | |
| Disease | Antihypertensive use measurement | 8.74e-04 | 265 | 82 | 5 | EFO_0009927 | |
| Disease | Necrotizing Enterocolitis | 1.01e-03 | 17 | 82 | 2 | C0520459 | |
| Disease | essential hypertension (is_implicated_in) | 1.13e-03 | 18 | 82 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | spine bone size | 1.13e-03 | 18 | 82 | 2 | EFO_0004508 | |
| Disease | asthma | 1.15e-03 | 751 | 82 | 8 | MONDO_0004979 | |
| Disease | platelet component distribution width | 1.19e-03 | 755 | 82 | 8 | EFO_0007984 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 1.27e-03 | 19 | 82 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | mosaic loss of chromosome Y measurement | 1.46e-03 | 80 | 82 | 3 | EFO_0007783 | |
| Disease | level of Phosphatidylinositol (18:0_18:2) in blood serum | 1.55e-03 | 21 | 82 | 2 | OBA_2045156 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.55e-03 | 447 | 82 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | neutrophil percentage of leukocytes | 1.55e-03 | 610 | 82 | 7 | EFO_0007990 | |
| Disease | serum iron measurement | 1.79e-03 | 86 | 82 | 3 | EFO_0006332 | |
| Disease | insulin sensitivity measurement | 1.86e-03 | 23 | 82 | 2 | EFO_0004471 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 2.02e-03 | 24 | 82 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | mean platelet volume | 2.08e-03 | 1020 | 82 | 9 | EFO_0004584 | |
| Disease | lymphocyte percentage of leukocytes | 2.53e-03 | 665 | 82 | 7 | EFO_0007993 | |
| Disease | optic disc size measurement | 2.59e-03 | 205 | 82 | 4 | EFO_0004832 | |
| Disease | Alzheimer disease, APOE carrier status | 2.60e-03 | 98 | 82 | 3 | EFO_0007659, MONDO_0004975 | |
| Disease | upper respiratory tract disorder | 2.75e-03 | 28 | 82 | 2 | MONDO_0004867 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RKSFTSLYKDRCSTG | 956 | Q5SW79 | |
| VSHSRKFSKCSILEY | 466 | O75077 | |
| DGTSRFTCKGKSIYH | 126 | P28332 | |
| TRKELFYKADGESCS | 266 | P01008 | |
| SRHKSKDRYCEKDGE | 626 | Q08289 | |
| SCAYLDKKHTIFGRV | 386 | Q13356 | |
| CHSEGVSRLFSKLDY | 206 | Q86V24 | |
| RSNEKLCEFHKTISY | 91 | Q13702 | |
| KLRSDEKHRDVCYSI | 491 | O94952 | |
| SDEDHCGGKLTYKAR | 3746 | Q9NZR2 | |
| NRRKDTKEIYTHFTC | 311 | P08754 | |
| KRTYAFGEKHDNCTT | 56 | Q8NI17 | |
| LKRSYVCHARSAKGE | 326 | Q9NPH3 | |
| VEKVGNRYFTSKCHS | 66 | Q9UHC1 | |
| KIFCRTYDIHDPKSS | 146 | Q5SWX8 | |
| DCRGSYKEFAVHLKR | 66 | Q02817 | |
| SKYKHDLAASCQGRV | 511 | Q9UL01 | |
| CLRKQRHGSDSEYTE | 581 | P54753 | |
| RTSLGRHTSCYIKDK | 106 | Q68G74 | |
| KESTKERHGYCTLGE | 91 | Q8TCJ0 | |
| CGRSYKQRSSLEEHK | 206 | Q13422 | |
| CGRSYKQRSSLEEHK | 201 | Q9UKS7 | |
| RKYSCDHNTSLSRLE | 811 | Q9UPN3 | |
| HKSYKIRFNSISCSD | 606 | P29474 | |
| AAYSSRFCKDDIKHG | 241 | Q9NR21 | |
| ADRTDGYLKRCTFHE | 216 | Q9UBL9 | |
| GFTLCKAYRHTSTEE | 56 | Q9P2J9 | |
| SKCSRKYITEFLDTG | 476 | Q9P2N4 | |
| SKCHEEGLDSYLRSF | 901 | Q5JSL3 | |
| SLRLKSCFTKDYEEH | 116 | P09603 | |
| ECKTGFRHLYKITSI | 471 | Q6V1X1 | |
| KYVDHRFSRKTCSTS | 546 | Q9ULH1 | |
| RDIESGYRIHCSKSS | 91 | Q9HAZ1 | |
| YIRCKDTGFHAAEKR | 211 | Q3B820 | |
| RHSIEKDYSSLCDKQ | 46 | P32298 | |
| FCGRSYKQRSSLEEH | 206 | Q9UKT9 | |
| VFKACDEDHKGYLSR | 26 | Q9BUY7 | |
| SKGAVVATYRKTHLC | 151 | Q86X76 | |
| HKGCSLKVLADSERY | 581 | Q66K64 | |
| YSLRSHSADGRCKAL | 221 | Q8NH37 | |
| RGIYSKKQHKTSCEA | 861 | Q9P2F6 | |
| EIGRSAKSYCEHTAR | 71 | Q7Z7C8 | |
| TECLARLHGKTTYEK | 666 | P02788 | |
| LHSKYVKGRDRSSCV | 781 | P30414 | |
| VDYKSIFSRHCTKED | 686 | Q9UPU3 | |
| KSSATGHCLKIYRTF | 1176 | Q8IZX4 | |
| CSKYFTTLSDLRKHI | 236 | Q14872 | |
| SKLDLRRHKKYTCGS | 241 | Q9HAZ2 | |
| SDVDLDKYRHTFCSL | 171 | Q6PJ21 | |
| HELSCEGISKSYVFR | 176 | Q15437 | |
| SCKDHVGYIFTTDRD | 356 | Q96FL8 | |
| TRRHIYDTKLGTDKC | 226 | Q99439 | |
| KKFRCSGSEDYRSRF | 481 | O75094 | |
| EECGKAFYRSSHLTE | 66 | Q49A33 | |
| CGKAFAYTSSLRRHE | 311 | Q9H0M5 | |
| CEKAFSYSGDLRVHS | 416 | Q8NDQ6 | |
| KECGKAYSFSSSLRI | 411 | Q15935 | |
| HIKDVKLSDSGRYDC | 366 | O15394 | |
| DCGKTFRKSSYLTQH | 296 | Q96NG5 | |
| KECGKSFRYRSHLTE | 411 | Q96SQ5 | |
| CGRSFAEYSSLRKHL | 316 | Q86VK4 | |
| CDKTFDRIGKYESHT | 366 | Q5SVQ8 | |
| KECGKSFRYRSHLTE | 411 | Q8TAU3 | |
| PYECSDREKAFIHKS | 306 | Q7Z340 | |
| SYAISFRAEGKIKHC | 701 | P19174 | |
| CEKSFRYSSDLIRHE | 371 | Q96JL9 | |
| TEDKFYLSDEHGKCR | 376 | Q5TYW1 | |
| KTFSCTYTLKRHERT | 341 | B2RXF5 | |
| IQFARTHTGDKSYKC | 226 | P21506 | |
| TTVKYSKIRSFHGQC | 616 | Q8IWR0 | |
| CGKAFYRSSKLTEHK | 511 | Q96N22 | |
| ECGKFFPYSSSLRKH | 361 | Q13106 | |
| YARTHRKKLTSSGCI | 1081 | O43314 | |
| LHKRSGTDTSFYRGK | 1391 | A3KMH1 | |
| KYKTELCRTFHTIGF | 191 | P47974 | |
| DCGKTFSYNSKLIRH | 276 | Q8N2I2 | |
| SGRKYSDHCEARASR | 76 | C9JLR9 | |
| KKCGKAYTRSSHLTR | 421 | Q96BR6 | |
| KAFKYSSNLCEHERT | 316 | Q9BS34 | |
| DSIFSKDKRKHCGYT | 586 | Q70EL1 | |
| RGCDKSYTHPSSLRK | 556 | Q96T25 | |
| EGYHSRQVTCKRTKA | 1501 | P82987 | |
| SKEAIDHDKRAYSFC | 206 | Q15349 | |
| ERTKGNKSSYHRLSE | 841 | Q92539 |